MARKETSAurobindo Pharma Shares in Focus After USFDA Issues 1 ObservationAli WaghbakriwalaAugust 24, 2026August 24, 2026 August 24, 2026August 24, 2026 Shares of Aurobindo Pharma were trading in the green and almost 1% higher on 24 August after the company received one observation from the US...
BUSINESSGranules India Resolves USFDA Observation at Virginia FacilityDhruva KulkarniNovember 5, 2025November 5, 2025 November 5, 2025November 5, 2025 Granules India has received a clean slate from the USFDA for its Virginia facility, marking a positive turn after recent regulatory challenges. The company announced...